Records containing: Obesity
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-17An Interventional Study Investigating the Effects of Probiotics on Body Weight and Metabolic Homeostasis
-
CLINICAL_TRIALS study record update · 2026-03-17The Effect of a Mobile Application Developed for Obese Children on Eating Attitudes, Eating Awareness, and Healthy Eating Self-Efficacy
-
CLINICAL_TRIALS study record update · 2026-03-17Cross-Sectional and Longitudinal Studies of 'Pre-Diabetes'
-
CLINICAL_TRIALS study record update · 2026-03-17An Intervention Study Investigating Effect of Dietary Protein Supplementation on Body Weight and Metabolic Homeostasis
-
CLINICAL_TRIALS study record update · 2026-03-16Warm Staple-Line Irrigation (37-40 °C) Before Omentopexy Reduces Early Bleeding After Laparoscopic Sleeve Gastrectomy: A Prospective Randomized Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-16Database and Biological Material Bank in Obesity Medicine of the Quebec Heart and Lung Institute - Laval University (IUCPQ-ULaval)
-
CLINICAL_TRIALS study record update · 2026-03-16MicrobiAr: Characterization and Follow-up of Microbiome and Health Indicators in Obese, Pre-Diabetes and Type 2 Diabetes Cohorts Undergoing a Plant-based Diet and Lifestyle Intervention
-
CLINICAL_TRIALS study record update · 2026-03-13A Phase 3, Randomized, Active- and Placebo-Controlled, Partially-Blinded Study to Compare the Efficacy and Safety of KAI-9531 Administered Once Weekly Versus Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
-
CLINICAL_TRIALS study record update · 2026-03-13An Open-label, Non-randomised, Fixed-sequence, Two Period, Phase I Trial to Evaluate the Effect of Different Doses of BI 456906 (Survodutide) on the Single Dose Pharmacokinetics of Bupropion, Caffeine and Midazolam on Otherwise Healthy Volunteers With Overweight or Obesity
-
CLINICAL_TRIALS study record update · 2026-03-13A Double-blind, Randomized, Placebo-controlled, Multiple-dose, Parallel Group With Nested Crossover Design Trial With Moxifloxacin as Positive Control to Evaluate the Effects of Multiple Subcutaneous Doses of BI 456906 in a Titration Scheme on Cardiac Safety Parameters in (Otherwise) Healthy Male and Female Subjects With Overweight/Obesity
-
CLINICAL_TRIALS study record update · 2026-03-13A Randomized Controlled Pilot Study of Polyethylene Glycol Loxenatide Plus LNG-IUS in Women With Endometrial Atypical Hyperplasia
-
CLINICAL_TRIALS study record update · 2026-03-13A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of IBI362 in Participants With Mild to Moderate Hypertension Complicated by Overweight/Obesity Who Have Not Received Antihypertensive Drug Treatment
-
CLINICAL_TRIALS study record update · 2026-03-13Home Intervention for Reducing Sugary Drinks and Obesity in Hispanic Women-infants
-
CLINICAL_TRIALS study record update · 2026-03-12A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
-
CLINICAL_TRIALS study record update · 2026-03-12A Phase 3, Randomised, Double-blind, Parallel-group, 76-week, Efficacy and Safety Study of BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity Without Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2026-03-12A Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic (PK) of Single-dose Administration of Semaglutide Nasal Spray (WL1006) in Adult Overweight or Obese Participants
-
CLINICAL_TRIALS study record update · 2026-03-12Efficacy and Safety of NNC0487-0111 s.c. Once-weekly Compared to Semaglutide s.c. Once-weekly in Participants With Overweight or Obesity, and Type 2 Diabetes (AMAZE 8)
-
CLINICAL_TRIALS study record update · 2026-03-11Workplace Health Promotion "So Healthy, Lose 99" Weight Loss Activity
-
CLINICAL_TRIALS study record update · 2026-03-11The Michigan Weight Navigation Program (MiWeigh) Study
-
CLINICAL_TRIALS study record update · 2026-03-11Unraveling the Role of Pro-Resolving Lipid Mediators of Inflammation and Their Receptors in Obesity-Associated Diseases: New Therapeutic Approaches for Maresin 1 (RESOLBE)
-
CLINICAL_TRIALS study record update · 2026-03-11Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder - OBOE-Mayo
-
CLINICAL_TRIALS study record update · 2026-03-11Predictors of Behavioral Obesity Treatment Outcomes
-
CLINICAL_TRIALS study record update · 2026-03-11Mindfulness and Acceptance Based Behavioral Treatment for Weight Loss
-
CLINICAL_TRIALS study record update · 2026-03-11The Impact of Weight Loss on Alzheimer's Disease Risk in Adults With Down Syndrome
-
CLINICAL_TRIALS study record update · 2026-03-11Effect and Safety of Semaglutide 7.2 mg Once-weekly in Participants With Obesity and Type 2 Diabetes